ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors

Elettra Merola^{1

2}

Affiliations

¹ Department of Medicine 1, Division of Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. elettra.merola@apss.tn.it.
² Department of Gastroenterology, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy. elettra.merola@apss.tn.it.

Comment

Elettra Merola. Ann Surg Oncol. 2022 Sep.

. 2022 Sep;29(9):5578-5579.

doi: 10.1245/s10434-022-11882-w. Epub 2022 May 17.

Elettra Merola^{1

2}

¹ Department of Medicine 1, Division of Endocrinology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. elettra.merola@apss.tn.it.
² Department of Gastroenterology, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy. elettra.merola@apss.tn.it.

No abstract available

Comment on

Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence.
Merola E, Pascher A, Rinke A, Bartsch DK, Zerbi A, Nappo G, Carnaghi C, Ciola M, McNamara MG, Zandee W, Bertani E, Marcucci S, Modica R, Grützmann R, Fazio N, de Herder W, Valle JW, Gress TM, Fave GD, de Pretis G, Perren A, Wiedenmann B, Pavel ME. Merola E, et al. Ann Surg Oncol. 2022 Sep;29(9):5568-5577. doi: 10.1245/s10434-022-11837-1. Epub 2022 May 18. Ann Surg Oncol. 2022. PMID: 35583694

1. Partelli S, Bartsch DK, Capdevila J, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255–65. - DOI
1. Genc CG, Jilesen AP, Partelli S, et al. A new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors. Ann Surg. 2018;267(6):1148–54. - DOI
1. Merath K, Bagante F, Beal EW, et al. Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: an analysis of the US Neuroendocrine Tumor Study Group. J Surg Oncol. 2018;117(5):868–78. - DOI
1. Merola E, Pascher A, Rinke A, Bartsch K, et al. Radical resection in entero-pancreatic neuroendocrine tumors: recurrence-free survival rate and definition of a risk score for recurrence. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11837-1 .